Weston Park Hospital ( Site 1607)

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)	Advanced Solid Neoplasms	Active, not recruiting	Phase 2	2026-08-14		NCT03742895
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)	Head and Neck Neoplasms, Neoplasms by Site, autosomal dominant Parkinson disease 4, neoplasm	Active, not recruiting	Phase 3	2026-07-31		NCT03765918

Clinical trials